{
    "code": "02024452",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024452",
    "time": "2015-08-23 11:45:37",
    "許可證字號": "衛署藥輸字第024452號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/05\/24",
    "發證日期": "95\/05\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202445208",
    "中文品名": "康瑞斯24小時持續性藥效錠",
    "英文品名": "Clarinase 24 Hour Extended Release Tablets",
    "適應症": "緩解過敏性鼻炎及感冒的相關症狀，如鼻塞、打噴嚏、流鼻水、搔癢和流眼淚。",
    "劑型": "121持續性藥效錠",
    "包裝": "2-7粒鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "LORATADINE, PSEUDOEPHEDRINE SULFATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1426201100  臺灣拜耳股份有限公司",
    "申請商地址": "台北市信義區信義路五段7號台北101大樓之53至54樓",
    "主製造廠": {
        "製造廠名稱": "F410130000  SCHERING-PLOUGH, S.A.",
        "製造廠廠址": "CTRA. NAL. I, KM.36-28750 SAN AGUSTIN DE GUADALIX (MADRID), SPAIN",
        "製造廠公司地址": "",
        "製造廠國別": "SPAIN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400005600",
            "成分名稱": "LORATADINE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212002620",
            "成分名稱": "PSEUDOEPHEDRINE SULFATE",
            "含量描述": "",
            "含量": "240.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Clarinase 24Hours ER Tablets Leaflet (Eng)_CCDS 122013-2014-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=008&Type=9"
        },
        {
            "title": "02024452001_2-2014-06-23.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=007&Type=9"
        },
        {
            "title": "02024452001_1-2014-06-23.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=006&Type=9"
        },
        {
            "title": "02024452001-2014-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=005&Type=9"
        },
        {
            "title": "Clarinase 24 Hour Extended Release Tablets PI___20120607.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=004&Type=9"
        },
        {
            "title": "Clarinase 24 Hour Extended Release Tablets PI (Eng)___20120607.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=003&Type=9"
        },
        {
            "title": "020244520002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=002&Type=9"
        },
        {
            "title": "020244520001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=001&Type=9"
        },
        {
            "title": "020244520003.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=005&Type=8"
        },
        {
            "title": "020244520002___20120607.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=004&Type=8"
        },
        {
            "title": "020244520002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=003&Type=8"
        },
        {
            "title": "020244520001___20120607.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=002&Type=8"
        },
        {
            "title": "020244520001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024452&Seq=001&Type=8"
        }
    ]
}